HIGHLIGHTS
- who: Sara Rodru00edguez-Mora and collaborators from the Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain Faculty of Sciences, Universidad de Alcalu00e1, Madrid, Spain have published the research: Persistent Immunity against SARS-CoV-2 in Individuals with Oncohematological Diseases Who Underwent Autologous or Allogeneic Stem Cell Transplantation after Vaccination, in the Journal: (JOURNAL)
- what: In this study both humoral and cellular immunity against SARS-CoV-2 were analyzed in 29 individuals with OHD who were vaccinated before receiving allogeneic (n = 11) or autologous (n = 18) HSCT. Due 16 of 19 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.